659
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Incidence, etiology and bone marrow characteristics of non‐chemotherapy‐induced agranulocytosis

, &
Pages 50-53 | Published online: 12 Nov 2013

References

  • Pisciotta AV. Drug-induced agranulocytosis. Peripheral destruction of polymorphonuclear leukocytes and their marrow precursors. Blood Rev 1990;4:226–37.
  • Andres E, Kurtz JE, Maloisel F. Nonchemotherapy drug-induced agranulocytosis: experience of the Strasbourg teaching hospital (1985–2000) and review of the literature. Clin Lab Haematol 2002;24:99–106.
  • Julia A, Olona M, Bueno J, Revilla E, Rossello J, Petit J, et al.. Drug-induced agranulocytosis: prognostic factors in a series of 168 episodes. Br J Haematol 1991;79:366–71.
  • Andres E, Kurtz JE, Perrin AE, Dufour P, Schlienger JL, Maloisel F. Haematopoietic growth factor in antithyroid-drug-induced agranulocytosis. QJM 2001;94:423–8.
  • Andres E, Kurtz JE, Martin-Hunyadi C, Kaltenbach G, Alt M, Weber JC, et al.. Nonchemotherapy drug-induced agranulocytosis in elderly patients: the effects of granulocyte colony-stimulating factor. Am J Med 2002;112:460–4.
  • Kaufman DW, Kelly JP, Jurgelon JM, Anderson T, Issaragrisil S, Wiholm BE, et al.. Drugs in the aetiology of agranulocytosis and aplastic anaemia. Eur J Haematol Suppl 1996;60:23–30.
  • Andres E, Zimmer J, Affenberger S, Federici L, Alt M, Maloisel F. Idiosyncratic drug-induced agranulocytosis: update of an old disorder. Eur J Intern Med 2006;17:529–35.
  • Lekhakula A, Swasdikul D. Drug-induced agranulocytosis: experience in two university hospitals. J Med Assoc Thai 1991;74:121–30.
  • Kaufman DW, Kelly JP, Issaragrisil S, Laporte JR, Anderson T, Levy M, et al.. Relative incidence of agranulocytosis and aplastic anemia. Am J Hematol 2006;81:65–7.
  • Theophile H, Begaud B, Martin K, Laporte JR, Capella D. Incidence of agranulocytosis in Southwest France. Eur J Epidemiol 2004;19:563–5.
  • Ibanez L, Vidal X, Ballarin E, Laporte JR. Population-based drug-induced agranulocytosis. Arch Intern Med 2005;165:869–74.
  • Hamerschlak N, Maluf E, Pasquini R, Eluf-Neto J, Moreira FR, Cavalcanti AB, et al.. Incidence of aplastic anemia and agranulocytosis in Latin America – the LATIN study. Sao Paulo Med J 2005;123:101–4.
  • Shapiro S, Issaragrisil S, Kaufman DW, Anderson T, Chansung K, Thamprasit T, et al.. Agranulocytosis in Bangkok, Thailand: a predominantly drug-induced disease with an unusually low incidence. Aplastic Anemia Study Group. Am J Trop Med Hyg 1999;60:573–7.
  • van Staa TP, Boulton F, Cooper C, Hagenbeek A, Inskip H, Leufkens HG. Neutropenia and agranulocytosis in England and Wales: incidence and risk factors. Am J Hematol 2003;72:248–54.
  • Rawson NS, Harding SR, Malcolm E, Lueck L. Hospitalizations for aplastic anemia and agranulocytosis in Saskatchewan: incidence and associations with antecedent prescription drug use. J Clin Epidemiol 1998;51:1343–55.
  • Andersohn F, Konzen C, Garbe E. Systematic review: agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med 2007;146:657–65.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.